David R. Wise
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 10
- Cancer Genomics and Diagnostics 6
- Biochemistry top 0.5%
- Amino Acid Enzymes and Metabolism 4
- Molecular Biology top 1%
- Genetics top 1%
- Hematology top 2%
-
- Prostate Cancer Treatment and Research 26
- Prostate Cancer Diagnosis and Treatment 8
-
- Cancer Immunotherapy and Biomarkers 9
- PARP inhibition in cancer therapy 4
-
- Radiopharmaceutical Chemistry and Applications 7
- Co-authors
- Craig B. ThompsonJustin R. CrossPatrick S. WardM. Celeste SimonAnthony MancusoMarc YudkoffRalph J. DeBerardinisIlana Nissim
- Journals
- Journal of Clinical Oncology (16 papers)Annals of Oncology (2 papers)European Radiology (2 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
David R. Wise
40 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 3.8k
- Biochemistry 680
- Molecular Biology 4.3k
- Genetics 648
- Hematology 559
Countries citing papers authored by David R. Wise
This map shows the geographic impact of David R. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Wise more than expected).
Fields of papers citing papers by David R. Wise
This network shows the impact of papers produced by David R. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Wise. The network helps show where David R. Wise may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David R. Wise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 17 | |
| 13 | 2019 | 3 | |
| 14 | 2012 | 303 | |
| 15 | 2011 | 145 | |
| 16 | 2011 | 30 | |
| 17 | The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutaratebreakdown → | 2010 | 1483 |
| 18 | Glutamine addiction: a new therapeutic target in cancerbreakdown → | 2010 | 1368 |
| 19 | Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addictionbreakdown → | 2008 | 1532 |
| 20 | 2008 | 167 |
About David R. Wise
David R. Wise is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Biochemistry and Radiology, Nuclear Medicine and Imaging, having authored 48 papers that have together received 6.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (26 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer Genomics and Diagnostics (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Cancer Research (3.8k citations), Biochemistry (680 citations), Molecular Biology (4.3k citations), Genetics (648 citations) and Hematology (559 citations). David R. Wise has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Craig B. Thompson, Justin R. Cross, Patrick S. Ward, M. Celeste Simon, Anthony Mancuso, Marc Yudkoff, Ralph J. DeBerardinis, Ilana Nissim, Evgueni Daikhin and Steven B. McMahon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Radiology, Journal of Nuclear Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.